Blog

China’s pharmaceutical industry is undergoing a profound structural transformation, and China pharmaceutical export trends are also changing significantly. From a past dominated by active pharmaceutical ingredient (API) exports to today’s expansion into high-end formulations, innovative…

In recent years, GLP-1 receptor agonists (GLP-1 RAs) have become one of the most closely watched therapeutic areas in the global weight-loss and metabolic disease treatment landscape. From early injectable therapies to today’s innovative oral…

Breast cancer is the most common malignancy among women worldwide, with incidence continuing to rise. Precision molecular subtyping and individualized therapies have improved outcomes, but tumor heterogeneity, antigen escape, and drug resistance remain major challenges.…

The landscape of approved cell and gene therapy drugs in China is rapidly evolving, as these advanced treatment approaches are increasingly recognized worldwide for their revolutionary potential in treating cancer, genetic disorders, and rare diseases.…

Currently, africa pharmaceutical industry challenges are increasingly recognized as a key issue in the global healthcare supply system. These challenges extend beyond drug access and also involve quality assurance, supply stability, and cross-border distribution efficiency.…

With the continuous restructuring of the global healthcare supply chain, China has become one of the most important sources of international pharmaceutical procurement. An increasing number of healthcare institutions, pharmaceutical distributors, research organizations, and medical…

In the context of continuous development of global healthcare systems, drug accessibility has become a critical factor influencing patient outcomes. Despite the rapid emergence of innovative therapies, high costs, complex cross-border distribution, and strict regulatory…

For patients living with transfusion-dependent beta thalassemia (TDT), lifelong blood transfusions have long been the standard of care. While effective in maintaining hemoglobin levels, this approach brings a significant burden—requiring frequent transfusions and continuous iron…

Antibody-drug conjugates (ADCs) are one of the fastest-growing classes of therapies in precision oncology. In this guide to adc drugs by target, we provide a comprehensive and updated overview of approved antibody-drug conjugates, together with…

As global drug patents continue to expire, the China Generic Drug Market Trends 2026 indicate that the industry is entering a new cycle of competition and opportunity. Around 2026, the Chinese pharmaceutical industry is approaching…

Liver cancer is one of the most serious and life-threatening cancers worldwide. According to the International Agency for Research on Cancer (IARC), liver cancer remains one of the leading causes of cancer-related deaths globally. As…

Colorectal cancer (CRC) is one of the most common malignant tumors worldwide and remains a leading cause of cancer incidence and mortality, according to the World Health Organization and the National Cancer Institute. In recent…